COHERUS BIOSCIENCES, INC. 5,172,413 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 25th, 2018 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
Coherus BioSciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,172,413 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 775,861 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
